Product Name | MF | CAS | Details |
---|
N-Formyl Pregabalin | C9H17NO3 | 1488274-42-5 | Details |
UNC569 | C22H29FN6 | 1350547-65-7 | Details |
PCO371 | C29H32F3N5O6S | 1613373-33-3 | Details |
(Rac)-BRD0705 | C20H23N3O | 1597440-03-3 | Details |
BRD0705 | C20H23N3O | 2056261-41-5 | Details |
KI696/KI-696 | C28H30N4O6S | 1799974-70-1 | Details |
Picosulfate Sodium EP Impurity A | C18H15NO5S | 51264-33-6 | Details |
Cilostazol USP RC B | C20H25N5O2 | 73963-62-9 | Details |
Lidocaine EP Impurity K HCl | C13H21ClN2O | 50295-20-0 | Details |
Vericiguat Impurity 6/5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide | C14H11F2N5 | 1350653-27-8 | Details |
Baricitinib Impurity 11/Tert-butyl 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-(cyanomethyl)azetidine-1-carboxylate | C19H21N7O2 | 1627504-41-9 | Details |
Baricitinib Impurity 12/1-(Propylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile | C17H19N7O2S | 1187594-34-8 | Details |
Epacadostat | C11H13BrFN7O4S | 1204669-58-8 | Details |
Delpazolid | C14H17FN4O3 | 1219707-39-7 | Details |
UM-164 | C30H31F3N8O3S | 903564-48-7 | Details |
CEP-40783 | C31H26F2N4O6 | 1437321-24-8 | Details |
IACS-10759 | C25H25F3N6O4S | 1570496-34-2 | Details |
2-Propenamide, 3-cyclopentyl- | C8H13NO | 1000538-32-8 | Details |
HA966 | C4H8N2O2 | 1003-51-6 | Details |
methyl 3-(1,2,2-trimethylhydrazinyl)propanoate | C7H16N2O2 | 101032-36-4 | Details |
Levofloxacin-005-S | C15H12F2N2O6 | 1012310-27-8 | Details |
Benzoyloxy acetaldehyde diethyl acetal | C13H18O4 | 101268-52-4 | Details |
(R)-Terazosin | C19H25N5O4 | 109351-34-0 | Details |
1H-Pyrazolo[4,3-d]pyriMidine, 7-ethoxy-5-[2-ethoxy-5-[(4- Methyl-1-piperazinyl)sulfonyl] phenyl]-1-Methyl-3-propyl- | C24H34N6O4S | 1093065-15-6 | Details |
2-Bromo-6-butoxypyridine | C9H12BrNO | 1092848-28-6 | Details |
Glycine, N-[[4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]- | C24H15ClF6N2O4 | 1092708-80-9 | Details |
2-CHLORO-N-(2,4-DIMETHYLPHENYL)PROPANAMIDE | C11H14ClNO | 109099-55-0 | Details |
Tryptophan-004 | C18H18O6 | 1084695-75-9 | Details |
2-Amino-5-bromopyridine | C5H5BrN2 | 1072-97-5 | Details |
Ropivacaine-iPr-R | C17H26N2O | 1050482-18-2 | Details |
Methyl 4-acetyl-2-Methylbenzoate | C11H12O3 | 1036715-60-2 | Details |
4-[(2,3-Dihydro-5,6-dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine Hydrochloride | C24H32ClNO2 | 1034439-57-0 | Details |
Benzo[b]thiophene-2-Methanol, α-(5-broMo-2-fluorophenyl)- | C15H10BrFOS | 1034305-11-7 | Details |
(S)-methyl 2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanoate | C8H14N2O3 | 1027601-37-1 | Details |
1H-Pyrazole, 4-broMo-1-(1-ethoxyethyl)- | C7H11BrN2O | 1024120-52-2 | Details |
S-217622 | C14H14BrNO2S | 1022243-82-8 | Details |
1-Piperidinecarboxylic acid, 4-[(1,3-dihydro-5,6-dimethoxy-1-oxo-2H-inden-2-ylidene)methyl]-, 1,1-dimethylethyl ester | C22H29NO5 | 1020717-67-2 | Details |
Mirabegron-003 | C8H7FN2O3 | 1018983-85-1 | Details |
5-bromo-2-fluoro-N-methylbenzamide | C8H7BrFNO | 1016777-86-8 | Details |
S-217622 | C7H4ClN3O2 | 101420-98-8 | Details |
N-(2,6-dimethylphenyl)piperidine-4-carboxamide | C14H20N2O | 109403-19-2 | Details |
Benzoic acid, 4-[3-(3,5-dichlorophenyl)-4,4,4-trifluoro-3-hydroxy-1-oxobutyl]-2-methyl- | C18H13Cl2F3O4 | 1095275-07-2 | Details |
Benzoic acid, 4-[3-(3,5-dichlorophenyl)-4,4,4-trifluoro-3-hydroxy-1-oxobutyl]-2-methyl-, compd. with N,N-diethylethanamine (1:1) | C24H28Cl2F3NO4 | 1095275-08-3 | Details |
Fluralaner-019-EYA | C22H24Cl2F3NO4 | 1095275-09-4 | Details |
Benzoic acid, 4-[3-(3,5-dichlorophenyl)-4,4,4-trifluoro-1-oxo-2-buten-1-yl]-2-methyl- | C18H11Cl2F3O3 | 1095275-26-5 | Details |
Ropivacaine-ET-S-HCl | C16H25ClN2O | 112773-86-1 | Details |
1-[3-Bromo-5-(trifluoromethyl)phenyl]-2,2,2-trifluoroethan-1-one, 3-Bromo-5-(trifluoroacetyl)benzotrifluoride | C9H3BrF6O | 1132701-00-8 | Details |
2,2'-IMinobis(N-(2,6-DiMethylphenyl)acetiaMide Hydrochloride | C20H26ClN3O2 | 1135231-62-7 | Details |
S-217622 | C7H7BrN2O2 | 1142382-25-9 | Details |
1(3H)-Isobenzofuranone, 3-(1-methylpropylidene)- | C12H12O2 | 114259-19-7 | Details |
[4-[1-(1-ethoxyethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl | C19H25N5O3 | 1146629-76-6 | Details |
1146629-80-2 | C23H28N6O2 | 1146629-80-2 | Details |
Elagolix-003-R-HCl | C34H35ClF5N3O5 | 1150560-46-5 | Details |
methyl 3-(2-bromopropanoylamino)-4-methyl-thiophene-2-carboxylate | C10H12BrNO3S | 1160919-46-9 | Details |
Elagolix-001 | C14H21NO5S | 110143-62-9 | Details |
Ropivacaine impurity | C12H14N2O3 | 1105704-96-8 | Details |
(4-bromophenyl)methanesulfonic acid | C7H7BrO3S | 110874-72-1 | Details |
Benactyzine-001 | C11H11Cl2NO4 | 111049-74-2 | Details |
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, 17-oxide, (5α)- | C20H23NO5 | 112269-62-2 | Details |
afoxolaner-016 | C22H13BrF6O4 | 1125726-30-8 | Details |
4-[3-[3-Chloro-5-(trifluoromethyl)phenyl]-4,4,4-trifluoro-3-hydroxy-1-oxobutyl]-1-naphthalenecarboxylic acid | C22H13ClF6O4 | 1125727-10-7 | Details |
4-acetyl-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}-1-naphthamide | C17H15F3N2O3 | 1125812-54-5 | Details |
4-{3-[3-chloro-5-(trifluoromethyl)phenyl]-4,4,4-trifluorobut-2-enoyl}-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}-1-naphthamide | C26H16ClF9N2O3 | 1125812-56-7 | Details |
1-[3-Chloro-5-trifluoromethylphenyl]-2,2,2-trifluoroethanone | C9H3ClF6O | 1125812-58-9 | Details |
1-Naphthalenecarboxylic acid, 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-, methyl ester | C23H14ClF6NO3 | 1125812-60-3 | Details |
1-Naphthalenecarboxylic acid, 4-[3-[3-chloro-5-(trifluoromethyl)phenyl]-4,4,4-trifluoro-1-oxo-2-buten-1-yl]-, methyl ester | C23H13ClF6O3 | 1125812-62-5 | Details |
Bifendate-007 | C12H14O6 | 1093864-55-1 | Details |
1093861-50-7 | C26H17BrF9N3O3 | 1093861-50-7 | Details |
Vilazodone Impurity 8 | C13H11ClN2O | 2512200-37-0 | Details |
Perindopril | C19H32N2O5 | 82834-16-0 | Details |
Bafilomycin A1 | C35H58O9 | 88899-55-2 | Details |
Metformin EP Impurity B HCl | C4H9ClN8 | 2959-04-8 | Details |
5-Vinylbenzo[d][1,3]dioxole | C9H8O2 | 7315-32-4 | Details |
2-Fluoroadenosine Monophosphate | C10H13FN5O7P | 1492-60-0 | Details |
Pramoxine Impurity 2 | C24H34O4 | 2749415-65-2 | Details |
Lidocaine EP Impurity F HCl | C14H23ClN2O | 857170-72-0 | Details |
Ethyl 4-bromo-1-methyl-1H-imidazole-2-carboxylate | C7H9BrN2O2 | 1260672-33-0 | Details |
FLT3-IN-10 | C15H11FN2O | 2088735-51-5 | Details |
NF-κΒ activator 2 | C16H11FN2O3 | 2375281-44-8 | Details |
Valecobulin Hydrochloride | C26H29ClN6O5S | 1240321-53-2 | Details |
IMP-1088 | C25H29F2N5O | 2059148-82-0 | Details |
PF-5190457 | C29H32N6OS | 1334782-79-4 | Details |
D-Desthiobiotin | C10H18N2O3 | 533-48-2 | Details |
DBCO-acid | C19H15NO3 | 1353016-70-2 | Details |
Src Inhibitor 3 | C34H32ClFN8O4 | 2380027-49-4 | Details |
(R)-Omeprazole | C17H19N3O3S | 119141-89-8 | Details |
Azaperol | C19H24FN3O | 2804-05-9 | Details |
Sitagliptin Impurity 51 | C14H14F3NO3 | 2248445-00-1 | Details |
TVB-3664 | C25H23F3N4O2 | 2097262-58-1 | Details |
2-Bromo-3-fluoro-4-iodo-pyridine | C5H2BrFIN | 1804910-90-4 | Details |
Isopropyl2-bromopropanoate | C6H11BrO2 | 7401-84-5 | Details |
(3b,5b,15a,16a)-15,16-Dihydro-3,5-dihydroxy-3'H-cycloprop[15,16]androsta-6,15-dien-17-one | C20H28O3 | 82543-15-5 | Details |
(S)-6-Methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-one | C8H8OS2 | 147086-79-1 | Details |
Abaloparatide Acetate Salt | C174H300N56O49 | 247062-33-5 | Details |
Rosuvastatin 5-Carboxylic Acid Impurity | C16H18FN3O4S | 1263475-93-9 | Details |
(2R,5R)-2,5-Diphenylpyrrolidine | C16H17N | 155155-73-0 | Details |
Diethyl (2-Oxo-2-phenylethyl)phosphonate | C12H17O4P | 3453-00-7 | Details |
Allyl 2,2,2-Trichloroacetimidate | C5H6Cl3NO | 51479-73-3 | Details |
Isononylphenol | C15H24O | 11066-49-2 | Details |
Methyl4-bromo-6-chloronicotinate | C7H5BrClNO2 | 1256790-93-8 | Details |
Product Total: Product Page: | ||||
77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 |